Christopher Marshall (doctor)

Christopher John Marshall FRS FMedSci was a British scientist who worked as director of the Division for Cancer Biology at the Institute of Cancer Research. Marshall was distinguished for research in the field of tumour cell signalling. His track record includes the discovery of the NRas oncogene , the identification of farnesylation of Ras proteins, and the discovery that Ras signals through the MAPKERK pathway. These findings have led to therapeutic development of inhibitors of Ras farnesylation, MEK and BRaf.

Marshall was born in Birmingham, UK, and educated at the King Henry VIII School, Coventry. He then studied Natural Sciences at the University of Cambridge followed by a DPhil in cell biology at the University of Oxford. His graduate studies were followed by postdoctoral work at the Imperial Cancer Research Fund laboratories at Lincolns Inn Fields in London and the DanaFarber Cancer Institute in Boston.

Source: Wikipedia